1. Patients with other uncontrolled infections (see 2.3.2 for definitions) 
2. Patients who received ATG, Campath, or other T cell immunosuppressive monoclonal antibodies in the last 28 days 
3. Received donor lymphocyte infusion in last 28 days 
4. Diagnosis of Omenn's syndrome or MHC class I deficiency 
5. Active and uncontrolled malignancy 
6. Pregnant or lactating 
7. Unable to wean steroids to ≤0.5 mg/kg/day prednisone. 
8. Patients with Grade 3 hyperbilirubinemia       
    

NCT02510404_exc_T9
Condition
other uncontrolled infections
NCT02510404_exc_T12
Drug
ATG
NCT02510404_exc_T13
Drug
Campath
NCT02510404_exc_T14
Drug
T cell immunosuppressive monoclonal antibodies
NCT02510404_exc_T15
Temporal
in the last 28 days
NCT02510404_exc_T16
Scope
ATG, Campath, or other T cell immunosuppressive monoclonal antibodies
NCT02510404_exc_T17
Procedure
donor lymphocyte infusion
NCT02510404_exc_T18
Temporal
in last 28 days
NCT02510404_exc_T19
Condition
Omenn's syndrome
NCT02510404_exc_T20
Condition
MHC class I deficiency
NCT02510404_exc_T21
Condition
malignancy
NCT02510404_exc_T22
Qualifier
uncontrolled
NCT02510404_exc_T23
Temporal
Active
NCT02510404_exc_T24
Condition
Pregnant
NCT02510404_exc_T25
Condition
lactating
NCT02510404_exc_T26
Drug
steroids
NCT02510404_exc_T27
Value
≤0.5 mg/kg/day
NCT02510404_exc_T28
Procedure
wean
NCT02510404_exc_T29
Drug
prednisone
NCT02510404_exc_T30
Negation
Unable
NCT02510404_exc_T31
Condition
hyperbilirubinemia
NCT02510404_exc_T32
Qualifier
Grade 3